The company said it is confident it can address the state health department's concerns and will reapply for approval as soon as possible.
This article has been updated from a previous version to provide more specific information about the AOAC certification of InstantLabs' assay.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.